Breaking- Serum Institute 1st Indian company to seek emergency use authorisation for Oxford COVID-19 vaccine Covishield in India, says PTI sources

According to the sources by PTI the Serum Institute of India(SII) vaccine maker company becomes the the vaccine maker company from India to seek emergency license for oxford COVISHIELD vaccine in India.

Recommended For You